Dermaceutic and exosomes: a rigorous scientific approach to an emerging trend

    Posted on March 12, 2026
    Dermaceutic and exosomes: a rigorous scientific approach to an emerging trend

    Long overlooked, these natural vesicles are now at the forefront of cosmetic innovation. 

    Understanding exosomes 

    Exosomes were discovered 30 years ago and identified as extracellular vesicles released through exocytosis. They were once considered merely a cellular waste disposal mechanism, but today they are recognized as playing a key role in intercellular communication. 

    Exosomes are tiny natural biological vesicles (30 to 150 nm) released by cells to facilitate intercellular communication. Rich in proteins, lipids, RNA, and DNA, they play a central role in tissue regeneration, immune response, and skin repair mechanisms. 

    This potential makes them attractive candidates for aesthetic applications, including collagen stimulation, elasticity improvement, and reduction of visible signs of aging. They can be found in certain topical treatments and/or combined with techniques such as microneedling. 

    However, several major challenges currently limit their effective and safe integration into cosmetic products: 

    • Quality variability depending on the cellular source 

    • Instability when exposed to pH variations, preservatives, and osmolarity 

    • Difficulty crossing the skin barrier without optimization technologies 

    • Lack of clear regulatory framework and limited human clinical trials 

    As true intercellular messengers, they open new perspectives in regeneration, protection, homeostasis, and skin revitalization. Their ability to transport active biomolecules makes them promising tools for designing smarter, more targeted, and biologically inspired skincare solutions. 

     

    Our response: proven and biomimetic technologies 

    Exosomes are one vectorization method among others already existing and used on the market. At Dermaceutic, we already offer products featuring advanced vectorization technologies: 

    Vitamin C Vectorization 

    Tri Vita C30, Light Ceutic, C25 Cream 
    Silanol-based technology to stabilize L-ascorbic acid and optimize its penetration. 

    Dermaceutic products formulated with Vitamin C vectorization: 

     

    Encapsulated Caffeine 

    Prolonged release without irritation, effectively targeting puffiness and dark circles. 

    Dermaceutic product formulated with encapsulated caffeine: 

     

    Smart Microemulsion Technology 

    Improved dispersion, stability, and efficacy of active ingredients. 

    Dermaceutic product formulated with smart microemulsion technology: 

     

    Biomimetic Textures 

    Formulations designed with high skin affinity to enhance performance. 

    Dermaceutic products formulated with biomimetic textures: 

     

    Our position: science, stability and transparency 

    Exosomes represent a significant advancement in delivery technologies within dermo-cosmetics. 

    Our priority:  

    • To develop products that are effective, stable, safe, and fully compliant with regulatory requirements. 

    • To master advanced encapsulation technologies, such as liposomes and nanospheres which are already widely validated and supported by scientific evidence. 

    • To explore biomimetic alternatives inspired by exosomes. 

     

    We believe in technological evolution rather than marketing-driven disruption. 

    Our R&D teams remain fully engaged in ongoing research on this topic, with the objective of identifying the type of exosome technology that would be most appropriate for our formulations; while remaining consistent with our formulation charter and the scientific rigor we are committed to upholding. 

    Back to blog